SRAX, an advertising technology company providing the tools to automate digital marketers and content owners’ campaigns across digital channels, named Colleen DiClaudio, 39, president of 340B Technologies, to its board of directors. With DiClaudio’s appointment, SRAX has nine board members.
“We are very pleased to have Colleen join our board. We believe Colleen’s experience in the healthcare space as an entrepreneur and an industry disruptor will be invaluable to SRAX and to our customers. We look forward to her contributions,” said SRAX CEO Christopher Miglino.
DiClaudio added, “I have experienced the efficiences technology can bring to healthcare, and I have witnessed the power of SRAXmd. In 2017, management has been focused on driving high-margin revenue and leveraging SRAX technology. I am excited to join the leadership team as the company enters its next phase.”
In an interview, Miglino had said,“In the future, every brand marketer will be focused on one-to-one engagement. It may not be the focus of their entire marketing effort, but it will be a massive part of the overall strategy. Two developments will determine this trend. First, with the increasing availability of 3rd party data, marketers will need to develop, grow and segment their 1st party data in order to maintain a competitive edge in their digital ad campaigns. At the same time, greater sophistication in attribution methods means they’ll be able to target customers at specific points of the customer journey, rather than at broad stages.”